Michal Lev-Ram, Senior Writer, FORTUNE

WELCOME

Before the calendar turned to 2020, and a local outbreak of a novel respiratory disease rampaged across the globe, we thought we knew the challenges that the U.S. healthcare system faced: escalating costs, focus on procedures rather than outcome, no preventive care to speak of. Then came COVID-19, which has opened our eyes to a new set of challenges — and a chance, at long last, to address all of these systemic issues and perhaps reinvent health care as we know it. 
Dr. David B. Agus, Professor of Medicine and Engineering; Founding Director and CEO, Lawrence J. Ellison Institute for Transformative Medicine, University of Southern California; Co-chair, FORTUNE Brainstorm Health 
Arianna Huffington, Founder and CEO, Thrive Global; Co-chair, FORTUNE Brainstorm Health 
Clifton Leaf, Editor-in-Chief, FORTUNE; Co-chair, Brainstorm Health

THE NEW PARADIGM

Seema Verma has more day-to-day authority over America’s health spending than anybody else. The CMS administrator oversees programs that provide healthcare to more than 130 million Americans and sets safety and quality standards within the health care system. Verma is also a senior member of the White House Coronavirus Task Force and was instrumental in the decision to change the way hospitals and providers operate during the COVID-19 pandemic, allowing for more flexibility. Are those changes here to stay? A candid conversation with Medicare’s boss. 
Seema Verma, Administrator, Centers for Medicare &amp; Medicaid Services 
Interviewer: Dr. David B. Agus, USC

LESSONS FROM THE PANDEMIC’S FRONTLINES

Business as usual is a thing of the past as companies and the country undergo a reopening after a months-long COVID-19 shutdown. In the ever-changing new normal, we’ll explore what smart, healthy business engagement looks like—and how companies are innovating, and even expanding, beyond the four walls of their old corporate domains. How do leaders build healthy societies and workforces? We’ll probe some bold ideas—and technologies—that can assist us in this journey. 
Dr. Gianrico Farrugia, President and CEO, Mayo Clinic 
Paul Roma, General Manager, IBM Watson Health 
Moderator: Clifton Leaf, Fortune

REOPENING. REIMAGINING. AND REGAINING TRUST.

Long before COVID-19 hit, Dr. Elvis Francois and Dr. William Robinson of the Mayo Clinic understood the power of music, seeing it as a form of medicine that can soothe the soul. Then they found themselves soothing the souls of millions of people around the world during the height of the pandemic. Their on-the-fly rendition of John Lennon’s “Imagine” went viral and became an anthem of hope for many during the most challenging days of COVID-19. The singing surgeons share why music connects people during difficult times—and prove it for the Brainstorm Health audience in a special performance. 
Dr. Elvis Francois, Orthopedic Surgery Resident, Mayo Clinic 
Dr. William Robinson, Orthopedic Surgery Resident, Mayo Clinic 
Moderator: Michal Lev-Ram, Fortune

IMAGINE: MAYO CLINIC DOCTORS ON THE POWER OF MUSIC 

The twin crises of COVID-19 and racial justice have revealed an inflection point that every business and leader must now address. Put simply: The U.S. and the world have changed, and every organization is now faced with the opportunity to thrive or fail in a suddenly unfamiliar landscape. How do leaders move forward when many of those they’ll lead are still hopeful for a return to more familiar routines? A candid conversation on leadership, quick decision-making, and that rare combination of traits that can drive organizations forward today: empathy and vision.
 
Niall Ferguson, Milbank Family Senior Fellow, Hoover Institution, Stanford University 
Anne Finucane, Vice Chairman, Bank of America 
Moderator: Arianna Huffington, Thrive Global

DECISION-MAKING IN THE TIME OF A PANDEMIC AND UNREST

As COVID-19 moves into its fifth month of destruction in the U.S., attention has focused almost exclusively on the daily challenges of rising infections, patchwork testing, and overwhelmed ICUs. In parallel, there are other, hidden health emergencies in our midst including mental health and opioid use disorders. It is going to take a convergence of humanity and technology to address both the seen and unseen pain of the pandemic. Verily’s Chief Medical and Scientific Officer Dr. Jessica Mega shares some shocking data on these crises, as well as solutions. 
Dr. Jessica Mega, Chief Medical and Scientific Officer, Verily Life Sciences

THE SEEN AND UNSEEN PAIN OF THE PANDEMIC

The onslaught of COVID-19 didn’t erase the many other illnesses afflicting millions of Americans daily. It’s a conundrum that doesn’t get much attention these days, but the simple fact is that we still have to take care of those with cancer, heart disease, and a thousand other ailments, both chronic and acute. How do health care systems balance these other urgent needs with their COVID-19 response? 
Joe Almeida, Chairman, President, and CEO, Baxter International 
Kieran Murphy, President and CEO, GE Healthcare 
Moderator: Dr. Margaret Hamburg, Foreign Secretary, National Academy of Medicine

BALANCING ACT

The impact of economic uncertainty, social distancing, isolation, widespread illness and death are driving a significant uptick in anxiety, stress, depression and overwhelming fear. Tackling these issues must be a priority, say some experts, if we are to stave off a mental health pandemic in the making. 
Dr. Joshua Gordon, Director, National Institute of Mental Health 
Karen Lynch, Executive Vice President, CVS Health, and President, Aetna 
Moderator: Arianna Huffington, Thrive Global

"FLATTENING THE SECOND CURVE”: THE POST-MENTAL HEALTH CRISIS

NETWORKING SESSIONS 

TAI CHI

NETWORKING AND FITNESS SESSIONS

The CEO of one of the world’s leading biotech companies joins us to discuss how the California company is battling the COVID-19 pandemic inside — and outside — the lab. Amgen CEO Bob Bradway shares some fundamental insights into the ongoing pandemic and explains why understanding everything we can about this virus will help us fight the next one. 
Robert Bradway, Chairman and CEO, Amgen
 Interviewer: Clifton Leaf, Fortune

BATTLING COVID-19 INSIDE AND OUTSIDE THE LAB

We’ve been here before. As a society, we’ve lived through epidemics, and even pandemics, and thanks to science, we’ve always come through stronger on the other side. Medical innovation and research have led to treatment and major advancements for HIV, cancer, and a host of infectious and genetic diseases. Science will prevail this time, too. The significant collaboration we are already seeing around treatments, vaccines, and prevention of COVID-19 will make us stronger and more resilient the next time a health crisis strikes. To get there, however, two things must remain true: medical research can’t stop at any one nation’s borders. And science must be driven by data, not politics. 
Dr. Giovanni Caforio, Chairman and CEO, Bristol-Myers Squibb 
Dr. Vas Narasimhan, Chief Executive Officer, Novartis
 Moderator: Dr. David Agus, USC

HOW SCIENCE IS GOING TO PREVAIL AND WHY COLLABORATION IS KEY

The protests that have catalyzed the nation and the world after the killing of George Floyd have made it more clear than ever that systemic racism remains a problem in the U.S. — and that it is more than a problem of even social justice: it is also both a public health and economic crisis. Black Americans have not only substantially higher death rates than white Americans from COVID-19 and other leading causes of death, they are also feeling the economic pain from the pandemic more deeply. Here’s how business can drive to the heart of this crisis and turn us into a healthier and more cohesive nation. 
Dr. Erin Thomas, Head of Diversity, Inclusion, and Belonging, Upwork 
Dr. Ashwini Zenooz, Chief Medical Officer and Senior Vice President, Healthcare and Life Sciences, Salesforce 
Moderator: Ellen McGirt, Senior Editor, Fortune

JUSTICE, HEALTH, AND WELL-BEING

Rapid response is critical to fighting pandemics. So is having a foundation of basic science on which to launch those rapid responses. Gene-editing pioneer Dr. Jennifer Doudna understands both. The co-developer of CRISPR shares how she and her team quickly repurposed their scientific facility into a COVID-19 testing lab that could process up to 3,000 samples a day and how some of the techniques used in gene editing apply to COVID testing. 
Dr. Jennifer Doudna, Professor, Molecular and Cell Biology, and Chemistry, University of California, Berkeley 
Interviewer: Sue Siegel, Board Member, Illumina, the Kaiser Family Foundation, Align Technology, and MIT The Engine

HOW CAN CRISPR FIGHT COVID-19?

When the pandemic hit and the NBA commissioner halted the season, his swift decision may have flattened the COVID-19 curve way beyond basketball. We talk with Adam Silver about the shutdown of pro sports, the importance of mental health awareness, and innovative ways of getting back on the hardwood. 
Adam Silver, Commissioner, National Basketball Association 
Interviewer: Adam Lashinsky, Executive Editor, Fortune

STAYING AHEAD OF THE GAME: NBA’S ADAM SILVER ON SHUTTING DOWN, REOPENING, CORONAVIRUS, AND THE MENTAL HEALTH FALLOUT

Out front in the high-stakes, international race to develop a vaccine against COVID-19 is Moderna Therapeutics, a 10-year-old firm that, until recently, few outside the biotech world had ever heard of. What Moderna has is the revolutionary technology—its messenger RNA platform—that has allowed the company to develop a vaccine to a highly infectious, emerging pathogen in record time (not to mention nearly two dozen other products in its pipeline). Moderna CEO Stéphane Bancel talks about his company’s coronavirus vaccine efforts and the technology powering them. 
Stéphane Bancel, Chief Executive Officer, Moderna 
Interviewer: Clifton Leaf, Fortune

FROM INFORMATION MOLECULE TO INFORMATION MEDICINE

VIRTUAL NETWORKING: CONNECTING WITH THE CO-CHAIRS

By invitation only 
Hosted by McKinsey &amp; Company 
For its myriad horrors, the COVID-19 pandemic has offered a once-in-a-generation opportunity to rethink healthcare. It’s a chance to pivot to prevention, say experts. And indeed a brand new report from the McKinsey Global Institute entitled “Prioritizing Health,” finds that by using interventions already in existence today, the global disease burden could be reduced by 40 percent over the next two decades. In this session, we’ll explore the economic and social benefits of reimagining healthcare along with how innovation in its truest sense—discovering improvements from the past and the future—can drive global health and prosperity. 
Amy McDonough, Senior Vice President and General Manager, Fitbit Health Solutions 
Mikelle Moore, Senior Vice President and Chief Community Health Officer, Intermountain Healthcare 
Asheesh Saksena, President, Best Buy Health 
Shubham Singhal, Healthcare Global Leader, Senior Partner, McKinsey & Company 
Clifton Leaf, FORTUNE

SPECIAL SESSION: WHEN HEALTH IS EVERYONE’S BUSINESS

Michal Lev-Ram, Senior Writer, Fortune

As societies, businesses, schools, and beyond continue to reemerge from a cold stop, a major challenge stares us straight in the face: How do we get people to listen and make safe decisions for themselves and for all of society? We’ll speak with leading behavior experts on how we can persuade people to make the right choices. We’ll look at lessons learned from unwise choices made during the pandemic. How do we help those who are stuck in old, destructive patterns when it comes to lifestyle, food, exercise, and more? And how do we address the health inequalities between different communities that have been highlighted in this pandemic? 
Dan Ariely, James B. Duke Professor of Psychology and Behavioral Economics, Duke University 
David Hoke, Senior Director, Health and Wellbeing, Walmart 
Van Jones, Chief Executive Officer, REFORM Alliance 
Moderator: Arianna Huffington, Thrive Global

BEHAVIOR CHANGE: THE ULTIMATE CHALLENGE IN OUR NEW NORMAL

HealthMap, the online global disease warning system, was among the first places to unearth evidence of the novel coronavirus in China. The team sent an automated alert to the WHO on December 30th—long before public reports—that a mysterious respiratory disease was spreading through Wuhan. The co-founder of HealthMap, Dr. John Brownstein, explains why this type of A.I. is critical and how it helps provide a continuously updated picture of the spread of any and every outbreak in the world. 
Dr. John Brownstein, Chief Innovation Officer, Boston Children’s Hospital

HEALTHMAP: A CORONAVIRUS-TRACKING BREAKTHROUGH

Staying true to Brainstorm Health’s core mission to focus on the intersection of health, technology, and innovation, we’ll dive into the latest breakthroughs in medical science and intervention. Contrary to what many might think, the pandemic hasn’t stalled emerging technologies, from telemedicine and AI to machine learning and robotics. Rather, it has given them new use cases. We’ll discover the coming generation of treatments, vaccines, and testing— and explore how health delivery is changing in the face of COVID-19. 
Dr. Amy Abernethy, Principal Deputy Commissioner, U.S. Food &amp; Drug Administration 
Dr. David Feinberg, Vice President, Google Health 
Moderator: Dr. David Agus, USC

AFTER THE PANDEMIC: TECHNOLOGY AND INNOVATION DRIVING BETTER HEALTH

COVID-19 has thrown a harsh spotlight on so many gaps—and frankly, failings—in society. It has exposed inequities in housing, education, employment, financial security, and health care. But it is also offering a rare opportunity that should not be ignored—a moment to reset and invest, to build better, healthier, more equitable communities. We delve into innovative ways to bring change. 
Dr. Julie Gerberding, Executive Vice President and Chief Patient Officer, Merck 
Michael Neidorff, Chairman, President, and CEO, Centene 
Interviewer: Dr. Michelle McMurry-Heath, President and CEO, Biotechnology Innovation Organization

INVESTING IN OUR COMMUNITIES: MORE URGENT THAN EVER

Many legacy health care systems and hospitals were already in dire shape before the coronavirus turned them on their heads. Hospitals now face a dramatic reduction in revenue without regularly scheduled elective surgeries, and some teeter on the verge of bankruptcy. Nurses, some of the heroes of our day, are being laid off if they don’t have necessary ICU training. As systems rewrite the rules around health care finances, we will dig into the long-term implications of this pandemic. How did the COVID-19 crisis make an already dysfunctional health care system even more so, and how can we repair it and invest in resiliency going forward? What role do technologies, like telemedicine, play in our reinvention of the hospital? And most important: What can we learn from the best? 
Dr. Marc Harrison, President and CEO, Intermountain Healthcare 
Paul King, President and CEO, Stanford Children’s Health 
Dr. Kyu Rhee, Vice President and Chief Health Officer, IBM 
Moderator: Clifton Leaf, FORTUNE

REINVENTING THE HOSPITAL

BRAINSTORM HEALTH LEADERSHIP AWARD

If COVID-19 has revealed anything, it is that health systems everywhere remain frighteningly fragile. In wealthy nations and those still developing, the pandemic has heightened inequities and left the most vulnerable even more exposed. A frank discussion about rebuilding infrastructure, supply chains, and a true health safety net for the poor. 
Dr. Agnes Binagwaho, Vice Chancellor, University of Global Health Equity; Senior Adviser, World Health Organization 
Dr. Sheila Davis, Chief Executive Officer, Partners in Health 
Moderator: Dr. Seth Berkley, CEO, Gavi, The Vaccine Alliance

RESHAPING GLOBAL HEALTH: COVID-19 AND THE ROAD AHEAD

“MEET FORTUNE” NETWORKING SESSIONS 
Ellen McGirt, Senior Editor, FORTUNE 
Sy Mukherjee, Writer, FORTUNE 
Adam Lashinsky, Executive Editor, FORTUNE 
Alan Murray, CEO, FORTUNE 
Jen Wieczner, Senior Writer, FORTUNE 
 
FITNESS SESSION

“MEET FORTUNE” NETWORKING AND FITNESS SESSIONS

As a former U.S. Army Ranger and graduate of West Point, Alex Gorsky knows about leading the charge in battle conditions. And, right now, there may be no bigger battle than stomping out a pandemic. The Johnson & Johnson CEO on what he believes are the globe’s biggest challenges during this crisis, the endeavor to deliver a billion doses of COVID-19 vaccines by 2021, and how the pandemic has affected health and medical care beyond the virus. 
Alex Gorsky, Chairman and CEO, Johnson &amp; Johnson 
Interviewer: Dr. David Agus, USC

JOHNSON & JOHNSON AND THE RACE FOR A VACCINE

There’s a shift underway in the healthcare landscape, a disruption that could provide underserved communities with access to doctors and services which have been difficult to reach, or simply unattainable and too costly. A discussion on this new wave of patient care: moving health care to where the health consumer is. Here’s how to make care not only more accessible to the masses, but get it delivered earlier — when it counts. 
Dr. Michelle Williams, Dean of the Faculty, T.H. Chan School of Public Health, Harvard University 
Interviewer: Arianna Huffington, Thrive Global

A NEW FRONT DOOR TO HEALTH CARE

One of the silver linings of this pandemic has been watching companies large and small pivot their businesses to respond. Enter Tempus. The Chicago-based technology company driven by A.I. has expanded into infectious diseases, starting with COVID-19. Founder and CEO Eric Lefkofsky shares details on the company’s shift, including their real-world evidence research project -- aiming to provide insights to reduce the impact of future pandemics.
Eric Lefkofsky, Founder and CEO, Tempus 
Interviewer: Dr. David Agus, USC

DISEASE AGNOSTIC: USING A.I. TO PIVOT TO AND COMBAT COVID-19

Since the launch of the Apple Heart Study in 2017, Apple and Stanford University School of Medicine have worked closely toward discovery of how technology innovation can usher in a new era of proactive healthcare. Their latest collaboration efforts during the COVID-19 crisis have expedited testing for first responders and increased virtual care options to protect patients and doctors. Stanford Medicine’s Dean Lloyd Minor and Apple Health’s Dr. Sumbul Desai discuss the growing role of digital innovation in healthcare, and the critical lessons they’ve learned about where technology can best support the response to COVID-19. 
Dr. Sumbul Desai, Vice President, Health, Apple 
Dr. Lloyd Minor, Carl and Elizabeth Naumann Dean, Stanford University School of Medicine 
Moderator: Clifton Leaf, Fortune

APPLE AND STANFORD MEDICINE: A COMMUNITY PARTNERSHIP

For its million downsides, COVID-19 has a singular upside: offering us an opportunity to reset and build a better, healthier workplace. What should this new space look like and how can it benefit all stakeholders? We delve into this question, one-on-one, with Chuck Robbins of Cisco. 
Chuck Robbins, Chairman and CEO, Cisco 
Interviewer: Arianna Huffington, Thrive Global

BUILDING A HEALTHIER “NEW NORMAL” IN THE WORKPLACE

BERNARD J. TYSON MEMORIAL LEADERSHIP AWARD

Sophie Grégoire Trudeau, gender equality advocate and mental health activist, was diagnosed with COVID-19 in the early stages of the pandemic. After recovering, Ms. Grégoire Trudeau leapt into action to help others suffering from the mental health repercussions of the coronavirus. She explores this often-overlooked challenge of COVID-19 -- from anxiety to isolation and depression -- and shares how to combat the stigma as well as her strategies for thriving amid the illness. 
Sophie Grégoire Trudeau, Gender Equality and Mental Health Advocate 
Interviewer: Arianna Huffington, Thrive Global

SOPHIE GRÉGOIRE TRUDEAU TACKLES COVID-19 AND MENTAL HEALTH

Lang Lang, Pianist, Educator, Philanthropist

SPECIAL PERFORMANCE AND MESSAGE

<h3>FORTUNE Brainstorm Health: The New Paradigm</h3>
Join Fortune’s Virtual Brainstorm Health Community: an exclusive network of corporate leaders, thinkers, inventors, entrepreneurs, and health policy innovators.
Our virtual conference, held&nbsp; July 7 and 8 focused on what we’ve learned from the COVID-19 pandemic, how we must reinvent health care and well-being, and how we can weather the continuing storm—and prepare for the next.
All of these virtual conversations will be enlightening, interactive, and engaging, and offer our community the opportunity to engage with peers and learn from leaders and innovators across the health and technology realms.
Speaker included: FORTUNE 500 CEOs from Johnson &amp; Johnson, Amgen, Cisco, Novartis, Baxter, Centene, and Bristol Myers Squibb; CEOs and senior leaders from Moderna, Merck, Walmart, Intermountain Healthcare, Bank of America, GE Healthcare, IBM Watson Health, Google Health, Mayo Clinic, the NBA, and Verily; and Government leaders at forefront of the crisis including the Centers for Medicare and Medicaid Services Administrator, the FDA Principal Deputy Commissioner, and the Director of the National Institute of Mental Health.

<h3>FORTUNE Brainstorm Health: The New Paradigm</h3>
Join Fortune’s Virtual Brainstorm Health Community: an exclusive network of corporate leaders, thinkers, inventors, entrepreneurs, and health policy innovators.
Our virtual conference, held&nbsp; July 7 and 8 focused on what we’ve learned from the COVID-19 pandemic, how we must reinvent health care and well-being, and how we can weather the continuing storm—and prepare for the next.
All of these virtual conversations will be enlightening, interactive, and engaging, and offer our community the opportunity to engage with peers and learn from leaders and innovators across the health and technology realms.
Speaker included: FORTUNE 500 CEOs from Johnson &amp; Johnson, Amgen, Cisco, Novartis, Baxter, Centene, and Bristol Myers Squibb; CEOs and senior leaders from Moderna, Merck, Walmart, Intermountain Healthcare, Bank of America, GE Healthcare, IBM Watson Health, Google Health, Mayo Clinic, the NBA, and Verily; and Government leaders at forefront of the crisis including the Centers for Medicare and Medicaid Services Administrator, the FDA Principal Deputy Commissioner, and the Director of the National Institute of Mental Health.

FORTUNE Brainstorm Health is going virtual, and our extraordinary community of corporate leaders, thinkers, inventors, entrepreneurs, and health policy innovators will gather for a series of conversations exploring our theme “The New Paradigm.”

Fortune Brainstorm Health is going virtual, and our extraordinary community of corporate leaders, thinkers, inventors, entrepreneurs, and health policy innovators will gather for a series of four conversations in June, culminating in a virtual conference on July 7–8 to explore our theme “The New Paradigm.”

Agenda